SCHEMBL5458255

SCHEMBL5458255

COc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ncc(F)cc3F)CC2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
MAPT P10636 5/20 0.51
HTR1A P08908 3/20 0.51
HTR1D P28221 3/20 0.51
HTR1B P28222 3/20 0.51
HTR2C P28335 2/20 0.51
HTR6 P50406 2/20 0.51
MTOR P42345 1/20 0.49
KDM4E B2RXH2 3/20 0.48
USP2 O75604 2/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPK1 P28482 1/20 0.47
HTR2A P28223 2/20 0.47
HTR7 P34969 1/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456043 0.87 GFER (0.58) ALDH1A1MEN1KMT2AMAPTHTR1A
SCHEMBL5460067 0.84 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AMAPTHTR1A
SCHEMBL5549915 0.84 MEN1 (0.64) ALDH1A1MEN1KMT2AMAPTHTR1A
SCHEMBL5459401 0.83 HSD17B10 (0.49) ALDH1A1MEN1KMT2AMAPTHSD17B10
SCHEMBL5460786 0.82 MAPT (0.48) ALDH1A1MAPTHTR1AHTR1DHTR1B
SCHEMBL5460880 0.81 MAPT (0.49) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL5458483 0.81 MEN1 (0.59) ALDH1A1MEN1KMT2AMAPTHTR1A
SCHEMBL5460590 0.80 MAPT (0.52) ALDH1A1MEN1KMT2AMAPTTSHR
SCHEMBL5455789 0.80 ALK (0.51) MAPTHTR1AHTR1DHTR1BHTR2A
SCHEMBL5460053 0.80 GLA (0.48) ALDH1A1KMT2AMAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 ALDH1A1 731/4885MEN1 1828/4885KMT2A 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.